Mediceo Paltac Holdings Co
Mediceo Paltac Holdings Co., a prominent player in the pharmaceutical and healthcare distribution industry, is headquartered in Japan. Established in 1948, the company has evolved significantly, expanding its operational reach across major regions in Asia. Specialising in the distribution of pharmaceuticals, medical devices, and healthcare products, Mediceo Paltac is recognised for its commitment to quality and innovation. The company’s core offerings include a diverse range of medical supplies and consumer health products, distinguished by their reliability and adherence to stringent safety standards. With a strong market position, Mediceo Paltac Holdings has achieved notable milestones, including strategic partnerships and a robust supply chain network, solidifying its reputation as a trusted distributor in the healthcare sector.
DitchCarbon Score
How does Mediceo Paltac Holdings Co's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Mediceo Paltac Holdings Co's score of 39 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Mediceo Paltac Holdings Co's reported carbon emissions
In 2023, Mediceo Paltac Holdings Co reported total carbon emissions of approximately 14,255,621,000 kg CO2e, with emissions distributed across various scopes. Specifically, Scope 1 emissions were about 28,439,000 kg CO2e, and Scope 2 emissions totalled approximately 46,552,000 kg CO2e. The majority of their emissions stemmed from Scope 3, which accounted for about 14,180,000,000 kg CO2e, including significant contributions from purchased goods and services (approximately 13,426,666,000 kg CO2e) and upstream transportation and distribution (about 110,073,000 kg CO2e). In comparison, the previous year, 2022, saw Scope 1 emissions of about 30,194,000 kg CO2e and Scope 2 emissions of approximately 45,890,000 kg CO2e, with limited Scope 3 data available. The total emissions for 2022 were not fully disclosed, indicating a potential increase in emissions in 2023. Mediceo Paltac Holdings has not set specific reduction targets or climate pledges, and there are no reported initiatives under the Science Based Targets initiative (SBTi) or other climate frameworks. The company’s emissions data is not cascaded from a parent organisation, indicating that it operates independently in its reporting and climate commitments. Overall, while Mediceo Paltac Holdings has made strides in emissions reporting, the absence of reduction targets highlights an area for potential improvement in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 32,573,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 49,959,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 00,000,000 | 00,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Mediceo Paltac Holdings Co is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
